India EU Free Trade Agreement: The historic Free Trade Agreement (FTA) signed between India and the European Union on Tuesday is expected to have a wide-ranging impact on the Indian economy and consumers. Under this agreement, tariffs on about 90 percent of European products imported into India have either been completely abolished or have been drastically reduced, which may significantly change the nature of the Indian import market in the coming years. It is estimated that this will almost double the presence of European goods in the Indian market and will save about 4 billion euros annually.
What is the impact on pharmaceuticals sector?
Especially the pharmaceutical and healthcare sector will get a big benefit from this, because the 22 percent tariff on chemicals and 11 percent tariff on medicines has been reduced to zero. Apart from this, duty on products like medical, surgical instruments and spectacles has also been reduced by 90 percent, which will reduce the cost of hospitals and treatment can become cheaper for the common people.
According to the Indian Commerce Ministry, the EU will cut customs duties on 99.5 percent of India’s exports over the next few years, including key sectors like marine products, leather, textiles, chemicals, rubber and gems and jewellery. This agreement, reached after two decades of long negotiations, is being considered the biggest trade agreement ever, which will create a common market of about two billion people.
Within three to four years of its implementation, bilateral trade is likely to exceed $200 billion and trade in services is likely to reach $125 billion. India is also expected to gain big in sectors like IT, professional services, education, finance, tourism and manufacturing, especially at a time when India is exploring new global trade options due to high tariffs imposed by the US.
Common market of 2 billion people
Also read: After India-EU FTA, from Olive Oil and plastic to medicines… know what is cheaper in India. complete list

